INTERNATIONAL PATENT: SAMJIN PHARMACEUTICAL CO., LTD., 삼진제약주식회사 FILES APPLICATION FOR "HETEROCYCLIC DERIVATIVE AS STING (STIMULATOR OF INTERFERON GENES) ACTIVATOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME"

GENEVA, March 24 -- SAMJIN PHARMACEUTICAL CO., LTD. (121 Wausan-roMapo-gu,Seoul 04054), 삼진제약주식회사 (서울특별시마포구와우산로 121) filed a patent application (PCT/IB2024/058923) for "HETEROCYCLIC DERIVATIVE AS STING (STIMULATOR OF INTERFERON GENES) ACTIVATOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME" on Sep 13, 2024. With publication no. WO/2025/057126, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Invent...